Ken Griffin Forte Biosciences, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Shares
14 transactions
Others Institutions Holding FBRX
# of Institutions
1Shares Held
175KCall Options Held
0Put Options Held
0About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $408M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.